Trial Profile

Phase 3 study of sildenafil/testosterone

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 01 Dec 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

27 Nov 2025 According to Freya Pharma Solutions media release, Freya Pharma Solutions has changed its name to Arletta Pharma Solutions.
19 Jun 2023 According to a Freya Pharma Solutions media release, the company announced that the United States (US) Food and Drug Administration (FDA) has responded with interest and provided valuable input regarding Freya Pharmas request for advice on the US Clinical Development Program of LybridoTM for the treatment of Female Sexual Interest/Arousal Disorder (FSIAD).
30 Sep 2022 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com